As the usual flurry of deals coincides with the J.P. Morgan Healthcare Conference, AbbVie signed an mRNA pact with Anima and a cancer research tie-up with Immunome.
Roche’s Genentech and Arsenal Biosciences (ArsenalBio) – a privately held programmable cell therapy company engineering advanced CAR-T therapies for solid tumours – have announced a multi-year collaboration to identify features of successful T-cell therapies for oncology and develop new understandings of their effects through preclinical analysis. Both companies will leverage their learnings in the development…
Genentech, Winterlight study finds speech analysis AI monitors Alzheimer's as well as standard tests
At a surface level, the sound of someone’s voice can offer insight into their mood and stress levels. | Vocal biomarkers have been linked to cardiovascular and respiratory conditions including COVID-19, as well as neurological diseases like depression, anxiety and even dementia—the last of which is in the crosshairs for speech analysis AI developer Winterlight…
Genesis Therapeutics, a Stanford University spinout company with a focus on artificial intelligence (AI), has entered into an agreement with Genentech, a member of the Roche Group, to further develop an AI-driven drug discovery platform to identify new drug candidates that target and treat several different severe diseases.
In this multi-target partnership, Genentech will leverage…